People
We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.


christian angermayer
co-founder & chairman of the board

aaron weaver
cfa
member of the board of directors

aksana labokha
phd
chief executive officer

caleb morgret
cfa
chief financial officer

karim allam
chief legal & people officer

stephen helliwell
phd
vp discovery biology

matthias steger
phd mba
co-founder

patrick schnider
phd
vp medicinal chemistry

prof. manuel serrano
phd
co-founder & scientific advisor - rejuveron senescence therapeutics

timothy cash
phd
co-founder & chief scientific officer - rejuveron senescence therapeutics

tristan heintz
phd
chief scientific officer - rejuveron vascular therapeutics

chien chi hsiao
head of medicinal chemistry - rejuveron vascular therapeutics

marianna feretzaki
phd
chief executive officer - rejuveron telomere therapeutics

wareed ahmed
phd
senior scientist - rejuveron telomere therapeutics

pierre-antoine mudry
bba ms
head, corporate finance and investor relations

kara chatelin
accounting officer in finance

daniele lionetti
msc
finance associate

naffi wade
director compliance & strategic projects

lisa caflisch
lab operations manager & bso

csaba budai
it operations manager

malaika schroeder
ma
director marketing & communications

dovaine picazo
team assistant
prof. hideyuki okano
md phd
member of the scientific advisory board

prof. lee rubin
phd
co-founder - rejuveron vascular therapeutics